Full Text Journal Articles by
Author Nathan M Hinkle

Advertisement

Find full text journal articles








Restaging Patients with Rectal Cancer Following Neoadjuvant Chemoradiation: A Systematic Review.

Leah E Hendrick, Renee L Levesque, Nathan M Hinkle, Justin J Monroe, Evan S Glazer, Jeremiah L Deneve, Danny Yakoub, David Shibata, Paxton V Dickson,

BACKGROUND:In the USA, most patients with clinical stage II/III rectal cancer receive neoadjuvant chemoradiation (chemo/XRT) over 5-6 weeks followed by a 6-10-week break before proctectomy. As chemotherapy is delivered at radio-sensitizing doses, there is essentially a 3-month window during which potential systemic disease is untreated. Evidence regarding the utility of restaging ... Read more >>

World J Surg (World journal of surgery)
[2020, 44(3):973-979]

Cited: 0 times

View full text PDF listing >>



The Impact of Ostomy Creation after Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in a Newly Established Peritoneal Malignancy Program.

Zachary E Stiles, Nathan M Hinkle, Gitonga Munene, Paxton V Dickson, Andrew M Davidoff, Jeremiah L Deneve,

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has improved outcomes for selected patients with peritoneal carcinomatosis and often requires ostomy creation. We examined the impact of ostomy creation in a newly established peritoneal malignancy program. A retrospective review was performed of CRS-HIPEC procedures from 2011 to 2016. Those who did ... Read more >>

Am Surg (The American surgeon)
[2018, 84(6):776-782]

Cited: 0 times

View full text PDF listing >>



Advertisement

The Impact of Early Recurrence on Quality of Life after Cytoreduction with HIPEC.

Nathan M Hinkle, Vandana Botta, John P Sharpe, Paxton Dickson, Jeremiah Deneve, Gitonga Munene,

Improved oncological outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in highly selected patients have been well documented. The extensive nature of the procedure adversely affects quality of life (QoL). The aim of this study is to longitudinally evaluate QoL following CRS/HIPEC. This is a retrospective review of ... Read more >>

Am Surg (The American surgeon)
[2017, 83(6):633-639]

Cited: 1 time

View full text PDF listing >>



Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.

Nathan M Hinkle, James MacDonald, John P Sharpe, Paxton Dickson, Jeremiah Deneve, Gitonga Munene,

Outcome measures after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for peritoneal carcinomatosis in established centers are well defined. However, results from newly emerging US centers have not been reported.This is a retrospective review of a prospectively maintained database of patients with peritoneal malignancies undergoing CRS/HIPEC.Fifty-six patients underwent exploratory laparotomy ... Read more >>

Am. J. Surg. (American journal of surgery)
[2016, 212(3):413-418]

Cited: 2 times

View full text PDF listing >>





Advertisement

Disclaimer
0.5467 s